Optimal therapy for multidrug-resistant tuberculosis and HIV
Lancet
.
2020 Aug 8;396(10248):363-365.
doi: 10.1016/S0140-6736(20)31688-3.
Authors
Harriet Mayanja-Kizza
1
,
Christine Sekaggya-Wiltshire
2
,
Desta Kassa
3
Affiliations
1
Department of Medicine, Makerere University, Kampala, Uganda. Electronic address:
[email protected]
.
2
Department of Medicine, Makerere University, Kampala, Uganda.
3
HIV/AIDS and TB Research Directorate, Ethiopian Public Health Institute, Addis Ababa, Ethiopia.
PMID:
32771093
DOI:
10.1016/S0140-6736(20)31688-3
No abstract available
Publication types
Comment
MeSH terms
Adult
HIV Infections*
Humans
Tuberculosis*
Tuberculosis, Multidrug-Resistant*